PerkinElmer Elects Frank Witney to Board of Directors
Get Alerts PKI Hot Sheet
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 1.2%
EPS Growth %: -58.1%
Join SI Premium – FREE
WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that Frank Witney, Ph.D., has been elected to the Company’s Board of Directors.
“I am delighted to welcome Frank to PerkinElmer’s Board, as he brings deep market knowledge and over 30 years of leadership experience across the life sciences, diagnostics and analytical instruments industry,” said Robert Friel, Chairman and Chief Executive Officer, PerkinElmer.
Most recently, Dr. Witney served as President and Chief Executive Officer of Affymetrix, Inc. (now part of Thermo Fisher Scientific), which specialized in microarray technology and cellular analysis. Previously, Dr. Witney was President and Chief Executive Officer of Dionex Corp., a market leading ion and high performance liquid chromatography company. Prior to that, Dr. Witney first joined Affymetrix when it acquired Panomics Inc., a quantitative biology company, which he led as President and Chief Executive Officer. Dr. Witney previously held the role of President of PerkinElmer’s Drug Discovery Tools division following the acquisition of Packard BioScience in 2001, where he served as President and Chief Operating Officer. Dr. Witney also held several positions at Bio-Rad Laboratories, leading that company's efforts to enter the proteomic and bioassay technologies market.
Dr. Witney was a post-doctoral fellow at the National Institutes of Health from 1980 to 1983 and holds a doctorate in molecular and cell biology from Indiana University. He earned an undergraduate degree in microbiology from the University of Illinois. He is currently Chairman of the Board for Gyros Protein Technologies AB and also holds Board positions for Cerus Corporation and Exagen Diagnostics.
About PerkinElmer, Inc.PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2.3 billion in 2015, has about 8,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160727006516/en/
PerkinElmer, Inc.
Brian Willinsky, +1-781-663-5728
[email protected]
Source: PerkinElmer, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sony/Apollo bid for Paramount could be worth as much as $29 billion - Source
- Bambuser Acquires the Tech Solution HERO from Klarna
- Boucher LLP Shines Light on Justice: Advocating for Victims of Sexual Assault, Abuse, and More
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Thermo Fisher Scientific/Dionex Corp., Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!